|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.6405 USD | -3.90% |
|
+2.79% | -59.46% |
| 08-27 | Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 | CI |
| 08-27 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OTLK | Delayed | |
Tradegate
| 41O | Real-time | |
CBOE
| OTLK | Real-time | |
Börse Stuttgart
| 41O | Delayed | |
Boerse Muenchen
| 41O | Real-time | |
Deutsche Boerse AG
| 41O | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 0.843 | 1.83 | 2.05 |
| Spread/Res. | -24.02% | -65.00% | -68.76% |
| Spread/Supp. | +5.17% | +223.32% | +207.78% |
| Support | 0.609 | 0.1981 | 0.2081 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OTLK Stock
- Charts Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















